ArticleClinical & experimental metastasis2026
Luteolin inhibits hyperglycemia-induced epithelial-mesenchymal transition and malignant progression in gastric cancer via targeting AKR1B1-mediated glucose metabolism.
Qin He et al.PubMed ↗Publisher ↗
No numbers read from the abstract.